Cargando…
Antibody-Mediated Rejection of the Heart in the Setting of Autoimmune Demyelinating Polyneuropathy: A Case Report and Review of the Literature
Background. Antibody-mediated rejection (AMR) is caused by the production of donor-specific antibodies (DSA) which lead to allograft injury in part via complement activation. The inflammatory demyelinating polyneuropathies (IDP) are inflammatory disorders of the nervous system, involving both cellul...
Autores principales: | Lindley, Kathryn J., Ravichandran, Ashwin K., Schilling, Joel, Joseph, Susan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008538/ https://www.ncbi.nlm.nih.gov/pubmed/24826264 http://dx.doi.org/10.1155/2012/639284 |
Ejemplares similares
-
Acute Inflammatory Demyelinating Polyneuropathy (AIDP) Masked by Autoimmune Thyroiditis
por: Wirtshafter, Stephanie, et al.
Publicado: (2021) -
A Rare Case of Autoimmune Demyelinating Polyneuropathy and
Hydrocephalus Secondary to Pembrolizumab
por: Arora, Aakriti, et al.
Publicado: (2020) -
Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018) -
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021) -
Chronic Inflammatory Demyelinating Polyneuropathy After Therapy With Infliximab Biosimilar
por: Larson, Jessica, et al.
Publicado: (2023)